Statistics for Oryzon Genomics SA (id:4763 ORY)
Valuation metrics
Market cap
98.44M
Enterprise value
99.87M
Trailing P/E (ttm)
-27.56
Forward P/E
-9.11
PEG ratio
-9.11
Price/Sales (ttm)
6.22
Price/Book (mrq)
1.15
Enterprise Value/Revenue
Enterprise Value/EBITDA
-23.43
Overview
Shares outstanding
63.59M
Float
53.51M
Shares short
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
141.46K
Average volume (90 days)
Price summary
52-Week low
1.49
52-Week high
2.38
52-Week change
-31.75%
Beta
3.00
50-Day moving average
1.70
200-Day moving average
1.83
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-28.78%
Operating margin
3.00%
Operational effectiveness
Return on assets
-3.14%
Return on equity
-4.10%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
13.95M
EBITDA
87.51K
Net income to common (ttm)
-4,340,185.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
0.00
Total cash per share (mrq)
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
Book value per share (mrq)
1.34
Cash flow
Cash flow statement
-3,798,910.00
Levered free cash flow (LFCF)
-3,352,943.00